Background: Inherent Limitations of Physical Membrane Permeabilization Techniques and Data Bottlenecks in Local Molecular Delivery R&D for Refractory Tumor Microenvironments

Conventional electroporation, a widely used in vitro technique, induces transient pore formation in the lipid bilayer of cell membranes through the application of artificial electric fields. However, its application in vivo, particularly in the complex and heterogeneous microenvironment of solid tumors, presents significant limitations. Specifically, the localized heat generation and subsequent protein denaturation, as well as the irreversible cell lysis caused by strong, uniform electric fields, distort the molecular baseline of target tissues and drastically reduce the efficiency of therapeutic gene delivery. The heterogeneous tissue resistance and spatiotemporal variations in electrical conductivity, inherent to interspecies differences, disrupt the downstream signaling pathways of cell membranes in the absence of in silico computational control systems, making it impossible to calculate genome correction coefficients for surviving cells. Furthermore, the receptor desensitization and negative feedback loops on cell membranes surrounding the applied current repeatedly fail to maintain the effective therapeutic concentration required for clinical efficacy, creating a data barrier in large-scale screening R&D. Although irreversible electroporation devices, such as the NanoKnife from AngioDynamics, have been introduced for local tumor ablation, the failure to control the electric field gradient at irregular tissue interfaces and the off-target toxicity caused by impermeable barriers remain significant challenges.

Discovery: Demonstration of Nano-Carrier and Bioelectronic Interface Activation, and Single-Cell Resolution Membrane Potential Independent Tensor Synchronization

To overcome these physical limitations, we developed a next-generation, biomaterial-assisted reversible electroporation technology that utilizes smart hydrogels, conductive polymer soft conductors, and porous nanoparticles to establish a highly localized electric field induction framework. Through precise molecular simulations at the nano-interface, we tuned the binding free energy between cargo molecules and lipid membranes, and in silico pre-calculated the pore formation kinetics of membrane permeabilization based on differential equations. By dynamically controlling the strength and pulse width of the input voltage, we suppressed unnecessary heat conduction and decomposition reactions, and introduced a batch effect computational removal algorithm. This platform, which surpasses conventional static delivery models, fixed the membrane permeability activation barrier within a controllable range and, at single-cell resolution, tracked and elucidated the dynamic changes in downstream transcriptional networks induced by exogenous transcripts that entered the cytoplasm. This is achieved by conductive nanocarrriers tightly binding to the surface of target cell membranes, concentrating the microelectric field, and successfully demonstrating high-efficiency CRISPR gene editing cargo delivery and complete molecular integrity while minimizing membrane damage.

Establishment of a Membrane Dynamics Pathway Regulation and Reversible Homeostatic Precision Layering Model

Based on a multidimensional omics matrix, this dynamic control loop projects the protein omics response to electrical stimulation intensity onto patient molecular phenotypes and family-specific genomic variation profiles, completing a patient-specific precision layering model. By mapping the lipid composition asymmetry and ion channel expression variations of the cell membrane into multidimensional tensor parameters, and defining a safe, reversible threshold line that ensures cell survival, we implemented up-clamping and down-clamping logic to autonomously adjust the rate-limiting step constants. By aligning the dynamic variables so that the ESCRT complex activation kinetics, the damage repair pathway, can function normally even under exogenous electrical stimulation, we maintained the reversible homeostasis of the cell in real time. By computationally predicting calcium flux overload within cells in atypical cellular stress environments and autonomously clamping the voltage pulse, we implemented a reversible stabilization backbone that permanently prevents the collapse of cells within the harsh solid tumor microenvironment. This precision layering model was applied to patient-derived tumor organoid models of various tissue origins, demonstrating the efficiency of membrane repair and optimizing the loading conditions for high-load genome cargo in each patient subgroup.

Prospects: Establishment of a Programmable Bioelectroceutical Standard and Activation of a Next-Generation IND Digital Governance

The convergence of computational genomics and bioelectronics will disrupt the existing static and experience-dependent post-hoc treatment and analysis systems, and redefine the governance of biomedical R&D through a programmable delivery infrastructure based on AI multidimensional tensor modeling. This platform will not only accelerate the diversification of intracellular delivery pathways for messenger ribonucleic acid and lipid nanoparticle pipelines in global multinational pharmaceutical companies, but also establish a computational moat by pre-controlling interference between nanomaterials and pulse media in high-throughput screening stages through the linkage of genetic gradient correction coefficients, thereby achieving zero batch-to-batch variation. This will fully meet the specifications of the companion diagnostic biochip interface, a key component of global digital healthcare, and will disruptively shorten the timeline for IND approval of new drug candidates in the preclinical stage by proactively demonstrating the optimal dosage efficacy under complex in vivo administration conditions. Furthermore, it will dramatically increase the large-scale manufacturing efficiency of next-generation immune cell therapies in cGMP production environments, establishing itself as a core governance element in the future advanced bio-regenerative medicine market.